The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

The conference runs from Monday through Thursday after two years of unprecedented underperformance for the healthcare sector.

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal ...

Can the upcoming J.P. Morgan Healthcare Conference next week trigger a flurry of biotech M&A deal making activity. Read more ...

The Westin St. Francis Hotel in Union Square will once again be host for one of the biggest conventions in the city--the J.P.

Security is top of mind at the JP Morgan Healthcare conference underway in San Francisco ...

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

Trump administrations pro-corporation policies boost healthcare M&A prospects Healthcare investment outlook improves as Trump ...